Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100976Source: DataRank Database

Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery is a research paper published in Cell Reports Medicine (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

gen hpa uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 4.84)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Trevor R. Nash ORCID,Xiaokan Zhang ORCID,Jenny Rao,Laura Abriola ORCID,Youngbin Kim ORCID

Live enrichment

PubMed:36921598 PMC:PMC10040415 OpenAlex:https://openalex.org/W4324195755

National Institutes of Health

Grant: P41EB027062

National Institutes of Health

Grant: UH3 EB025765

NHLBI NIH HHS

Grant: K08 HL140201

NHLBI NIH HHS

Grant: R01 HL076485

NHLBI NIH HHS

Grant: R01 HL140934

National Institutes of Health

Grant: 4UH3EB025765-03

Multi-tissue platform for modeling systemic pathologies

National Institutes of Health

Grant: 5P41EB027062-03

Tissue Engineering Resource Center

FWCI

4.84

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xcrm.2023.100976

publisherhttps://doi.org/10.1016/j.xcrm.2023.100976

publisherhttps://api.elsevier.com/content/article/PII:S2666379123000824?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666379123000824?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36921598

Fields of Study

Cardiomyopathy and Myosin StudiesCRISPR and Genetic EngineeringCardiac electrophysiology and arrhythmias0303 health sciences03 medical and health sciencesHumansCardiomyopathy, RestrictiveTissue EngineeringMyocytes, CardiacMyocardiumDrug Discovery

MeSH Terms

Cardiomyopathy, RestrictiveHumansMyocardiumTissue EngineeringMyocytes, CardiacDrug Discovery

Keywords

Induced pluripotent stem cellCRISPRCardiomyopathyDiastoleGenome editingDrug discoveryMedicinePharmacologyInternal medicineCardiologyBiologyBioinformaticsHeart failureGeneticsEmbryonic stem cellTissue engineeringRestrictive CardiomyopathyFlncHigh Throughput Drug ScreenMyocytesCardiomyopathy, RestrictiveMyocardiumRestrictive610600ReportHumansMyocytes, CardiacCardiac

Sustainable Development Goals

SDG 0: Good health and well-being

Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery

FAIR Checklist

Authors (21)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)